![]() |
Having been a pharmacy technician at Mott
Childrens Hospital for 10 years before entering the College, P-4
Sherry DeLoach would see formulations
being compounded and wonder: Who invented these? How did they know
a certain formulation would be stable for 30 days, refrigerated? She also saw the names of Professor Cary
Johnson, PharmD72, and Clinical Assistant Professor Deborah
Wagner, BSPharm76, PharmD82, on a lot of these same custom
formulations. So for DeLoach,
the opportunity she and classmate Brenda
Cichon-Hensley had to work, elbow-to-elbow, with Johnson
and Wagner on their PharmD investigations project was more than a fruitful
collaboration: It was a great honor, she says. My investigations project taught me that I had the capacity to
do research: not at the same level as faculty researchers, of course,
but at a high enough level to make fundamental contributions to the advancement
of medicine, DeLoach says.
This whole experience has allowed me to test and improve my clinical
and research skills. I chose pharmacy because I wanted to be a front-line health care
provider, she adds. More than any other benefit I have derived
from this experience is the knowledge that I have been part of a discovery
that will alleviate the suffering of children in pain. To me, thats
as good as it gets. The PharmD research project undertaken by DeLoach
and Cichon-Hensley was to determine
if tramadol, a centrally acting, synthetic codeine analog used to treat
moderate to moderately severe pain, could be reformulated from a tablet
to a liquid formulation with an extended, stable shelf-life. They discovered that it could. Tramadol, pulverized and suspended in Ora-Sweet SF® and strawberry
syrup flavored liquid preparations remained stable for 90 days both at
room temperature and refrigerated, retaining at least 99.04 percent of
the initial concentration. Presenting their findings as a poster at the
American Society of Health-System Pharmacists (ASHP) 37th Annual Mid-Year
Clinical Meeting in Atlanta, Dec. 8-12, was a fantastic experience,
recounts Cichon-Hensley. Even as we fine-tuned our ASHP presentation in advance of the meeting,
it was still mainly a PharmD project in my mind, she notes. But
when we were actually at the meeting, presenting our findings to practicing
clinicians who wanted to learn what we had found, I understood how even
relatively small contributions can have a direct impact on patient care.
It was a reality check for me. The tramadol study has been submitted for publication. Meanwhile, DeLoach
and Cichon-Hensley have teamed
up with Johnson and Wagner
for a second research project and article: this one exploring whether
a new tramadol/acetaminophen combo tablet can be reformulated as a liquid
dosage form. While neither and DeLoach nor
Cichon-Hensley have immediate plans
to pursue a research career after graduation, both say that their investigations
experience will make them better pharmacists, whatever practice path they
eventually choose. Anytime you take on a challenging project and complete it, you
are changed by the experience, Cichon-Hensley
says. I can already see ways of combining a career in direct patient
care with research that measures how medications or pharmacist interventions
affect patients quality of life. There was one other lesson she came away with. It was a great experience working with Drs. Johnson and Wagner, not just because they are excellent teachers, but also because they are nice people and dedicated professionals, she says. When you work with them, day-to-day, you really appreciate what they do and the contributions they make to improving patients lives. |
|
|
Sitemap
| Feedback
| Faculty&Staff Intranet
| University of Michigan
428 Church Street / Ann Arbor, MI 48109-1065 / (734) 764-7312 ©2003 / page last modified: Thursday, 13-Mar-2003 09:48:16 EST |